| AML | Acute Myelogenous Leukemia Morphologic Classification(FABºÐ·ù) 1. M0; Acute Undifferentiated Leukemia 2. M1; AML without Differentiation(Maturation); Myeloblast Prominence 3. M2; AML with Differentiation(Maturation); Myeloblast & Promyelocyte 4. M3; Acute Promyelocyte Leukemia; Promyelocyte Predominate; DIC °¡ Àß»ý±è 5. M4; Acute Myelomonocytic Leukemia; Myelocyte & Monocyte 6. M5; Acute Monocytic Leukemia; Promonocyte or Undifferentiated Blast * M4 & M5 ; Extramedullary Involve°¡ ¸¹´Ù. 7. M6; Acute Erythroleukemia; Erythroblast(ÁÖ) + Myeloblast(ÀϺÎ) 8. M7; Megakaryocytic Leukemia; Pleomorphic Undifferentiated |
|---|---|
| AML | acute monocytic leukemia; acute mucosal lesion; acute myeloblastic leukemia; acute myelocytic leukemia; acute myelogenous leukemia; anatomic medullary locking; angiomyolipoma; anterior mitral leaflet; automated multitest laboratory |
| AMLB | alternate monoaural loudness balance |
| AMLC | adherent macrophage-like cell; autologous mixed lymphocyte culture |
| AMLR | autologous mixed lymphocyte reaction |
| AMLS | antimouse lymphocyte serum |
| AMLSGA | acute myeloblastic leukemia surface glycoprotein antigen |
| AML | Acute Myeloblastic Leukaemia |
|---|---|
| AML | Acute Myelogenous Leukaemia |
| AML | Acute Myeloid Leukaemia |
| AML | Acute myeloblastic |
| AML | Acute myelocytic leukemia |
| AML | Angiomyolipoma |
| AML | acute myeloid |
| AML | anterior mitral leaflet |
| AML-M0 | acute myeloid leukaemia |
| AMLL | acute mixed lineage leukemia |
| t-AML | Therapy-related acute myeloid leukemia |
|---|
| AML | <haematology> A rapidly progressing cancer of the blood affecting immature cells of the bone marrow, usually of the white cell population. It is much more common in adults than in children. Symptoms include fatigue, weight loss, fevers, weakness, pallor, bone pains, bleeding gums, nosebleeds, easy bruising, enlarged lymph nodes and joint pains. Treatment includes chemotherapy and/or bone marrow transplant. This leukaemia demonstrates granulocyte differentiation, eosinophilia and Auer rods and is associated with a reciprocal translocation between 8 and 21 (q22;q22), which is the most common translocation in acute myeloid leukaemia and is found more often in younger patients than in older patients. The oncogene involved in this translocation is AML1, which can be detected by Southern blot. Numerical abnormalities, particularly monosomy-7, trisomy-4, trisomy-8, trisomy-21, -Y, monosomy-7 and deletions of the long arms of chromosomes 5 and 7 are quite common in all acute myeloid leukaemia and not restricted to any one FAB classification. Many of these abnormalities are observed at diagnosis and at later stage disease, particularly after chemotherapy. Prognosis is generally more favorable than in FAB-M2 patients showing no translocation, because the latter patients show better remission rates for longer periods of time. Immunophenotyping is useful in diagnosis and expression of one or more of the myeloid antigens CD13, CD14 or CD33 must be detected to make a diagnosis of acute myeloid leukaemia. Acronym: AML Incidence: 2,000 new cases per year in the UK. Origin: Gr. Haima = blood (07 Apr 1998) |
|---|---|
| amlodipine | <chemical> 2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylic acid 3-ethyl 5-methyl ester. A long-acting dihydropyridine calcium channel blocker. It is effective in the treatment of angina pectoris and hypertension. Pharmacological action: antihypertensive agents, calcium channel blockers, vasodilator agents. Chemical name: 3,5-Pyridinedicarboxylic acid, 2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-, 3-ethyl 5-methyl ester (12 Dec 1998) |
Synonyms : Almirall Brand of Amlodipine Besilate, Amlodipine Besylate, Amlodipine Maleate, Amlodipine Maleate (1:1), Amlodipine, (+-)-Isomer, Amlodipine, (+-)-Isomer, Maleate (1:1), Amlodipine, (R)-Isomer, Amlodipine, (S)-Isomer, Maleate (1:1), Amlor, Astudal, Istin
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|---|---|---|---|
|
³ë¹Ù½ºÅ©Á¤5mg - »õâ
|
Çѱ¹ÈÀÌÀÚ |
A03102361 | Amlodipine besylate | Àü¹®ÀǾàǰ | »èÁ¦ |
|
³ë¹Ù·ÎÇÉĸ½¶ - »õâ
|
Áᨚ |
A02107661 | Amlodipine maleate | Àü¹®ÀǾàǰ | ±Þ¿© |
|
½ºÄ«µåÁ¤ - »õâ
|
SKÄɹÌÄ® |
A18901951 | Amlodipine maleate | Àü¹®ÀǾàǰ | ±Þ¿© |
|
¾Ö´ÏµðÇÉÁ¤ - »õâ
|
Á¾±Ù´ç |
A01207381 | Amlodipine maleate | Àü¹®ÀǾàǰ | ±Þ¿© |
|
¾Æ¸ðµðÇÉÁ¤ - »õâ
|
Çѹ̾àǰ |
A21404061 | Amlodipine camsylate | Àü¹®ÀǾàǰ | ±Þ¿© |
|
¾Ï·ÎÇÉĸ½¶5mg - »õâ
|
À¯ÇѾçÇà |
A04506641 | Amlodipine maleate | Àü¹®ÀǾàǰ | ±Þ¿© |
|
¾Ï·Î½ºÅ¸Á¤5mg - »õâ
|
¾¾Á¦ÀÌ |
A11603411 | Amlodipine adipate | Àü¹®ÀǾàǰ | ±Þ¿© |
|
¾Ï·Îµð¾ÆÁ¤5mg - »õâ
|
ÇÑÀϾàǰ°ø¾÷ |
A01050671 | Amlodipine adipate | Àü¹®ÀǾàǰ | »èÁ¦ |
|
¿¡ÀÌ¿¥Á¤ - »õâ
|
ÄÚ¿À·ÕÁ¦¾à |
A04705321 | Amlodipine maleate | Àü¹®ÀǾàǰ | ±Þ¿© |
|
¾Ï·ÎÇÉĸ½¶2.5mg - »õâ
|
À¯ÇѾçÇà |
A04506691 | Amlodipine maleate | Àü¹®ÀǾàǰ | ±Þ¿© |
| amlodipine besylate |
a vasodilator (trade name Norvasc) taken in tablet form; prescribed for hypertension and angina pectoris
Ãâó: wordnet.princeton.edu/perl/webwn
|
|---|---|
| amlodipine besylate |
(am
Ãâó: www.mercksource.com/pp/us/cns/cns_hl_dorlands.jspz...
|
| AML |
An acute form of leukaemia, a malignant disease of the white blood cells affecting monocytes or granulocytes. It is characterised by the appearance of immature, abnormal cells in the bone marrow and peripheral blood.
Ãâó: depts.washington.edu/registry/glossary.htm
|
| AML |
Army Medical Library, Library pertaining and run by the Army Medical Center
Ãâó: users.skynet.be/jeeper/Terms%20A.html
|
| AML |
An acute onset cancer of the white blood cells where the cancer arises in the bone marrow.
Ãâó: www.dva.gov.au/health/HlthStdy/validation/glossary...
|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|